-
公开(公告)号:US20170137878A1
公开(公告)日:2017-05-18
申请号:US15343279
申请日:2016-11-04
发明人: Mong Sano Marma , Jerzy Olejnik , IIia Korboukh
IPC分类号: C12Q1/68
CPC分类号: C12Q1/6869 , C07C323/12 , C07C323/60 , C07C2603/18 , C07D207/46 , C07F7/1804 , C07H19/10 , C07H19/14 , C09B1/00 , C09B5/2436 , C09B11/24 , C09B23/083 , C09B23/166 , C12Q1/6811 , C12Q1/6876 , Y02P20/55
摘要: The present invention provides methods, compositions, mixtures and kits utilizing deoxynucleoside triphosphates comprising a 3′-O position capped by a group comprising methylenedisulfide as a cleavable protecting group and a detectable label reversibly connected to the nucleobase of said deoxynucleoside. Such compounds provide new possibilities for future sequencing technologies, including but not limited to Sequencing by Synthesis.
-
公开(公告)号:US20170121361A1
公开(公告)日:2017-05-04
申请号:US15119622
申请日:2015-02-18
CPC分类号: C07H13/02 , A61K47/549 , C07H5/02 , C07H15/203 , C07H17/075 , C07H19/10 , C07K1/1077 , C08H1/00 , C12P19/18 , C12P19/26 , C12P21/005
摘要: This invention provides compound having a structure of Formulas: Furthermore, methods and uses of such compounds for covalently bonding to a sugar acceptor, to form modified protein therapeutics having reduced enzymatic hydrolysis, improved biological stability or an improved pharmacokinetic property.
-
公开(公告)号:US20170112868A1
公开(公告)日:2017-04-27
申请号:US15378576
申请日:2016-12-14
申请人: Novartis AG
发明人: Sampath-Kumar Anandan , Virender Singh Aulakh , Martijn Fenaux , Xiaodong Lin , Liang Mao , Oliver Saunders , Zachary Kevin Sweeney , Fumiaki Yokokawa , Weidong Zhong
IPC分类号: A61K31/7072 , A61K45/06 , A61K47/22 , C07H19/06
CPC分类号: A61K31/7072 , A61K31/7068 , A61K45/06 , A61K47/22 , C07H19/06 , C07H19/067 , C07H19/10
摘要: The present invention provides a compound of formula A: or a pharmaceutically acceptable salt thereof, wherein B, Q, R1, R5, R6, R7, R8 and Z are defined herein, which is a 2′-branched nucleoside useful for the treatment or prevention of viral infections, particularly dengue virus, yellow fever virus, West Nile virus, Japanese encephalitis virus, tick-borne encephalitis virus, Kunjin virus, Murray Valley encephalitis, St Louis encephalitis, Omsk hemorrhagic fever virus, bovine viral diarrhea virus, Zika virus and Hepatitis C virus.
-
公开(公告)号:US09605310B2
公开(公告)日:2017-03-28
申请号:US14821566
申请日:2015-08-07
CPC分类号: C12Q1/6869 , C07H19/10 , C07H19/20 , C07H21/00 , C12P19/34 , C12Q1/6806 , C12Q1/6818 , C12Q1/6823 , C12Q1/6834 , C12Q1/6874 , C12Q1/6876 , C12Q2525/186
摘要: Nucleosides and nucleotides are disclosed that are linked to detectable labels via a cleavable linker group.
-
公开(公告)号:US09605018B2
公开(公告)日:2017-03-28
申请号:US14608523
申请日:2015-01-29
发明人: Guangyi Wang , Leonid Beigelman
IPC分类号: A61K31/70 , C07H19/04 , A01N43/04 , C07H19/10 , C07H19/20 , A61K31/7056 , A61K31/7072 , A61K31/7076 , A61K31/708 , A61K38/21 , A61K45/06 , C07H19/207 , A61K31/381 , A61K31/497
CPC分类号: C07H19/20 , A61K31/381 , A61K31/497 , A61K31/7056 , A61K31/7072 , A61K31/7076 , A61K31/708 , A61K38/21 , A61K45/06 , C07H19/10 , C07H19/207
摘要: Disclosed herein are phosphorothioate nucleotide analogs, methods of synthesizing phosphorothioate nucleotide analogs and methods of treating diseases and/or conditions such as viral infections, cancer, and/or parasitic diseases with the phosphorothioate nucleotide analogs.
-
公开(公告)号:US09598455B2
公开(公告)日:2017-03-21
申请号:US14673403
申请日:2015-03-30
申请人: CEPHEID
发明人: Alexander A. Gall , Sergey G. Lokhov , Mikhail A. Podyminogin , Ekaterina V. Viazovkina , Kevin Patrick Lund
IPC分类号: C07H19/04 , C07H21/04 , C12Q1/68 , C07H19/06 , C07H19/10 , C07F9/6574 , C07K14/00 , C07H19/073
CPC分类号: C07H19/06 , C07F9/65744 , C07H19/073 , C07H19/10 , C07H21/00 , C07H21/04 , C07K14/003 , C12Q1/6813 , C12Q1/6832 , C12Q2525/117
摘要: Disclosed are modified thymine bases that provide enhanced base-pairing affinity for adenine or 2,6-diaminopurine bases in polynucleotide hybridization complexes. Also disclosed are polynucleotide oligomers, polynucleotide hybridization complexes that comprise such modified thymine bases. Also disclosed are various methods of use. For example, in some embodiments, modified polynucleotide oligomers disclosed herein can be used as primers and probes for nucleic acid amplification and/or detection.
-
47.
公开(公告)号:US20170073752A1
公开(公告)日:2017-03-16
申请号:US15361083
申请日:2016-11-25
发明人: Tsu-Ju Fu , Shang-Chia Chang , Jenn-Yeh Fann
IPC分类号: C12Q1/68
CPC分类号: C07H19/10 , C12Q1/6869 , C12Q1/6876 , C12Q2525/113 , C12Q2563/107
摘要: This invention is to describe nucleotide analogs used in a method for the determination of a nucleic acid sequence. The method involves an enzyme, an enzyme complex or plural number of enzymes with more than one enzymatic activity and a set of nucleotide analogs, to achieve high signal readout accuracy in nucleic acid sequencing by making each signal to have a long signaling time span which allows a higher signal clarity.
摘要翻译: 本发明是描述用于确定核酸序列的方法中使用的核苷酸类似物。 该方法包括酶,酶复合物或具有多于一种酶活性的多种酶和一组核苷酸类似物,以通过使每个信号具有长的信号时间跨度来实现核酸测序中的高信号读出准确度,这允许 更高的信号清晰度。
-
48.
公开(公告)号:US20170066795A1
公开(公告)日:2017-03-09
申请号:US15123124
申请日:2015-03-05
发明人: John Zoltan Sulliva-Bolyai , Benjamin Alexander Mayes , Douglas Lytle Mayers , Xiao-Jian Zhou , Adel M. Moussa , Alistair James Stewart , Sindhura Ganga , Clinton Scott Shultz , Alfred Lee
IPC分类号: C07H19/10 , A61K9/48 , A61K31/7072 , A61K9/20
CPC分类号: C07H19/10 , A61K9/20 , A61K9/2018 , A61K9/2077 , A61K9/48 , A61K9/4858 , A61K31/7072 , C07B2200/13
摘要: Provided herein are compounds, compositions and methods for the treatment of Flaviviridae infections, including HCV infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents. In certain embodiments, the compounds are solid forms of Compound I: (Compound I)
摘要翻译: 本文提供了用于治疗黄病毒科感染(包括HCV感染)的化合物,组合物和方法。 在某些实施方案中,公开了核苷衍生物的化合物和组合物,其可以单独施用或与其它抗病毒剂组合施用。 在某些实施方案中,化合物是化合物I的固体形式:(化合物I)
-
49.
公开(公告)号:US09567364B2
公开(公告)日:2017-02-14
申请号:US13811295
申请日:2011-07-20
申请人: Zhen Xi , Zicai Liang , Jinyu Huang
发明人: Zhen Xi , Zicai Liang , Jinyu Huang
IPC分类号: C07H21/02 , C07H21/04 , C07H21/00 , C07H19/04 , C07H19/20 , C07H19/10 , C07H19/048 , C07H19/167
摘要: Nucleotide and/or oligonucleotide represented by formula (1) and the liquid phase synthesis process thereof. The present invention provides a liquid phase synthesis process for preparing a nucleotide and/or an oligonucleotide, comprising a process for combining the nucleotide and/or oligonucleotide protective groups, in which, under the condition that the 2′-hydroxyl group is protected by a group with a sterically hindered silane structure, the 3′ phosphate group(s) of the nucleotide and/or oligonucleotide is/are directly protected by (a)β-cyanoethyl group(s), and after the β-cyanoethyl group(s) is/are removed, the resulting product can directly participate in the next cycle of synthesis, wherein the synthesis reaction is carried out in a reaction flask or reaction kettle, without being limited by a solid carrier or synthesizer, so that the large scale preparation of oligonucleotides can be achieved.
摘要翻译: 由式(1)表示的核苷酸和/或寡核苷酸及其液相合成方法。 本发明提供了制备核苷酸和/或寡核苷酸的液相合成方法,包括将核苷酸和/或寡核苷酸保护基组合的方法,其中在2'-羟基被 具有空间位阻硅烷结构的基团,核苷酸和/或寡核苷酸的3'磷酸基团被(a)2-氰基乙基直接保护,并且在2-氰基乙基之后, 所得产物可以直接参与下一个合成循环,其中合成反应在反应烧瓶或反应釜中进行,而不受固体载体或合成仪的限制,从而大规模制备 可以实现寡核苷酸。
-
公开(公告)号:US20170029455A1
公开(公告)日:2017-02-02
申请号:US15238553
申请日:2016-08-16
发明人: Ioannis Nicolaos Houpis , Tim Hugo Maria Jonckers , Pierre Jean-Marie Bernard Raboisson , Abdellah Tahri
IPC分类号: C07H19/10
CPC分类号: C07H19/10 , A61K31/7072 , C07H19/06 , C07H19/11 , C07H19/24
摘要: The present invention relates to compounds of the formula I: including any possible stereoisomers thereof, wherein R9 has the meaning as defined herein,or a pharmaceutically acceptable salt or solvate thereof.The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HCV inhibitors, in HCV therapy.
摘要翻译: 本发明还涉及制备所述化合物的方法,含有它们的药物组合物及其在HCV治疗中单独或与其它HCV抑制剂组合的用途。
-
-
-
-
-
-
-
-
-